rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Kevin Finney

Director

Company insider

Files Form 4 as: Director, Vaxart.

In numbers

Trades disclosed
14
Buys
5
Sells
0
Bought
$62K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
28 Jan 2025
Last trade
16 Jul 2026
Last filed
20 Jul 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
VaxartDirector · Biotechnology · last 16 Jul 20265 buys · 0 sells

Activity over time

1 Jul 2025 – 1 Oct 2026
04Jul 25Nov 25Mar 26Jun 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
16 Jul 2026filed 20 Jul 2026VaxartBiotechnologySEC FORM 4 Code A—39,400 at $0.00filing
16 Jul 2026filed 20 Jul 2026Vaxartoption or derivative · BiotechnologySEC FORM 4 Code A—78,700 at $0.00filing
16 Jul 2026filed 20 Jul 2026Vaxartoption or derivative · BiotechnologySEC FORM 4 Code A—78,700 at $0.00filing
16 Jul 2026filed 20 Jul 2026VaxartBiotechnologySEC FORM 4 Code A—39,400 at $0.00filing
15 Aug 2025filed 19 Aug 2025VaxartBiotechnologySEC FORM 4 Bought$18K50,000 at $0.35filing
15 Aug 2025filed 19 Aug 2025VaxartBiotechnologySEC FORM 4 Bought$19K50,000 at $0.37filing
30 Jul 2025filed 19 Aug 2025VaxartBiotechnologySEC FORM 4 Bought$9,83225,874 at $0.38filing
28 Jul 2025filed 19 Aug 2025VaxartBiotechnologySEC FORM 4 Bought$8,00020,000 at $0.40filing
25 Jul 2025filed 19 Aug 2025VaxartBiotechnologySEC FORM 4 Bought$7,80020,000 at $0.39filing
17 Jul 2025filed 19 Aug 2025VaxartBiotechnologySEC FORM 4 Bought$302794 at $0.38filing
13 Jun 2025filed 16 Jun 2025Vaxartoption or derivative · BiotechnologySEC FORM 4 Code A—36,392 at $0.00filing
13 Jun 2025filed 16 Jun 2025VaxartBiotechnologySEC FORM 4 Code A—6,103 at $0.00filing
28 Jan 2025filed 29 Jan 2025Vaxartoption or derivative · BiotechnologySEC FORM 4 Code A—190,800 at $0.00filing
28 Jan 2025filed 29 Jan 2025VaxartBiotechnologySEC FORM 4 Code A—32,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care5

Buys in green, sells in red, by the company’s sector.

Related people

Raquel C. BonoDirector · Director at Vaxart, filing Form 4 there in the last year
James B. BreitmeyerDirector · Director at Vaxart, filing Form 4 there in the last year
W. Mark WatsonDirector · Director at Vaxart, filing Form 4 there in the last year
Elaine J. HeronDirector · Director at Vaxart, filing Form 4 there in the last year
David E. WheadonDirector · Director at Vaxart, filing Form 4 there in the last year